advancing innovation to save lives

The Hill features op-ed from GHTC director

The Hill featured an op-ed from GHTC Director Jamie Bay Nishi which highlights the historic decline in US government investment in neglected disease R&D and calls for the US to increase funding and reassert American leadership in global health innovation.
View

Pipeline of Promise

Learn about the global health R&D process through our interactive Pipeline of Promise infographic.
Learn More

International AIDS Vaccine Initiative

The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Gabe Bienczycki
Global health coalition urges G20 pledge on pandemics and neglected diseases

A coalition of global health organizations, including GHTC, has called on the G20 to provide leadership in combating pandemics, drug resistance, and major poverty-related and neglected diseases.

Learn More
PATH/Gabe Bienczycki
Devex features World Malaria Day op-ed from GHTC director

Devex featured an opinion piece from GHTC Director Jamie Bay Nishi highlighting the need for innovative, technological solutions to end the epidemic of malaria. It also highlights the incredible successes of R&D in response to the epidemic.

View
View All News & Events

Member Event

PATH/Gabe Bienczycki
TB and European Health Security: The critical role of TB R&D in the context of AMR
Ministry of Health, Welfare and Sport of the Netherlands, Ministry of Foreign Affairs and International Development of France
Learn More

GHTC Event

PATH/Doune Porter
Investing in R&D from AMR to Zika: Laying the foundation for sustainable development
GHTC, MMV, PATH, TB Alliance
Learn More
View All Events
PATH/Doune Porter
Research Roundup: Progress in fighting NTDs and TB, Polio eradication setbacks, and the crisis surrounding Chagas

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Gabe Bienczycki
Opening up malaria drug discovery for good

Scientists are exploring new open innovation and open source approaches to catalyze malaria drug development and move us closer to achieving the goal of ending malaria for good.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide